Jeff Andreson
Analyst · Karl Ackerman from Cowen and Company. Your question, please
Yes. Good question. So, I think if you took the color and you ran it, and you probably know that at the high end, our gross margin is fairly similar. I’d say the fixed cost has been -- is probably, versus maybe the third quarter, the biggest change that’s negatively affected the gross margin. Product mix will affect it a little bit, but not as much as we're seeing in the fixed cost. Having said that, we always look to drive efficiencies. So, I would not say anything is off the table, as we look at our facilities across the board. There are some potential opportunities to do some additional integration either in the businesses and/or in the facility. So, we will constantly look at that as well and work on that. And we're also -- we had a lot of capacity last year, we probably didn't had as much as we thought as we were coming into the year. We modulated some of that back. So, we’ve right sized some of that as well. Now, one of the points, Karl, I think is important here is that as we talk about these market share wins, and this $75 million, that will be hitting the top line with very, very, very little incremental fixed costs along with it. Most of the capacity, as Jeff just said, is actually a place. There'll be a few more things to do. But beyond that, on the OpEx line, there'll be very, very, very little hiring, if you will, or increases in OpEx to support that extra bulk of dollars. And so, the leverage that we like to see through those fixed cost I think will become very visible through the year. And obviously, when we're bolting on that much more money with very, very, very little -- more in the way of fixed cost. It will be apparent to everyone.